These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Effect of of cervical antitumoral immunity activation on CIN]. Cappello F. Minerva Ginecol; 1991 Sep; 43(9):405-8. PubMed ID: 1945029 [Abstract] [Full Text] [Related]
3. [Dysplasia and carcinoma in situ of the uterine portio. Clinical, histopathological and histochemical findings]. Bertaglia A, De Gaetani CF, Trentini GP. Arch De Vecchi Anat Patol; 1974 Aug; 60(1):29-41. PubMed ID: 4470381 [No Abstract] [Full Text] [Related]
4. Use of B.C.G. as loco-regional aspecific immunostimulator in cervical carcinoma. Cappello F, Corradi P, Meli G. Clin Exp Obstet Gynecol; 1984 Aug; 11(4):156-7. PubMed ID: 6388907 [Abstract] [Full Text] [Related]
5. [The spread of uterine cancer in relation to therapy planning]. Pickel H. Gynakol Rundsch; 1987 Aug; 27 Suppl 2():17-20. PubMed ID: 3428707 [No Abstract] [Full Text] [Related]
8. [Morphologic structure of cancer of the cervix uteri and its metastasis to the pelvic lymph nodes]. Vinnits'ka VK. Pediatr Akus Ginekol; 1969 Aug; 4():55-7. PubMed ID: 5364489 [No Abstract] [Full Text] [Related]
9. [Cancer of the cervix and endometrium--treatment of recurrence]. Bauer J. Rev Med Suisse Romande; 1994 Oct; 114(10):927-30. PubMed ID: 7973307 [No Abstract] [Full Text] [Related]